Finance

Lists
1177:HKG
Sino Biopharmaceutical Ltd
HK$5.09
0.00%
(0.00) 1D
Jul 28, 4:08:22 PM GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 1177...
Open
HK$5.11
High
HK$5.13
Low
HK$5.01
Mkt. cap
470.78B
Avg. vol.
114.55M
Volume
36.61M
Dividend
1.96%
Quarterly dividend
HK$0.03
Ex-dividend date
Mar 30, 2027
P/E ratio
33.87
52-wk high
HK$9.12
52-wk low
HK$4.19
EPS
HK$0.15
Shares outstanding
12.64B
No. of employees
27K
Open
HK$5.11
High
HK$5.13
Low
HK$5.01
Mkt. cap
470.78B
Avg. vol.
114.55M
Volume
36.61M
Dividend
1.96%
Quarterly dividend
HK$0.03
Ex-dividend date
Mar 30, 2027
P/E ratio
33.87
52-wk high
HK$9.12
52-wk low
HK$4.19
EPS
HK$0.15
Shares outstanding
12.64B
No. of employees
27K
News stories
From sources across the web
Profile
China Mobile is the trade name of both China Mobile Limited, and its ultimate controlling shareholder, China Mobile Communications Group Co., Ltd., a Chinese state-owned telecommunications company. It provides mobile voice and multimedia services through its nationwide mobile telecommunications network across mainland China and Hong Kong. China Mobile is the largest wireless carrier in China, with 945.50 million subscribers as of June 2021. China Mobile was ranked #25 in Forbes' Global 2000 in 2023. China Mobile is listed on the Shanghai Stock Exchange as A-shares and the Hong Kong Stock Exchange as H shares. It is the world's largest mobile network operator by total number of subscribers, and the world's largest telecommunications company by revenue. As of 8 July 2025, China Mobile Limited's total market value stood at US$240 billion. Wikipedia
About Sino Biopharmaceutical Ltd
CEOGreg Reid | Ngit Liong Wong | Ngit Liong Wong | Pham Van Phong | Li Yi | Danny Le | Vincent Chong | David J. Rosa | Kim Yin Wong | Tan Su Shan | Michael S. Dell | He Biao
Employees27.3K
FoundedJan 31, 2013
HeadquartersChiyoda City, Tokyo, Japan
SectorMining
Previous reportsAll values in SGD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in SGD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
-
-
Operating expense
-
-
-
-
Total operating expenses
-
-
-
-
Operating income
-
-
-
-
Other non operating income
-
-
-
-
EBT including unusual items
-
-
-
-
EBT excluding unusual items
-
-
-
-
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-
-
-
-
Net profit margin
6.81%
0.93%
0.93%
50.89%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more